The incubator is designed to draw cell and gene therapy researchers and drugmakers to work at the hub, where they can develop ...
Gov. Kathy Hochul on Tuesday announced a $150 million investment in a new state-of-the-art cell and gene therapy hub to be ...
Medpage Today on MSN16h
Evidence of Durable Vision Improvement With Gene Therapy for Retinitis PigmentosaCHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely ...
MedPage Today on MSN14h
MIND Diet and Cognitive Decline; Gene Therapy for Parkinson's; Curbing MS FatigueA high dose of the investigational gene therapy AAV-GAD, which delivers the glutamic acid decarboxylase ( GAD) gene to the ...
The biotech engaged with the FDA on alternative pathways to approval after seeing safety and efficacy data from the phase 1/2 ...
Editas Medicines has signed a $238 million biobucks pact to combine Genevant Science’s lipid nanoparticle (LNP) tech with the ...
The National Institutes of Health has awarded an assistant professor of biomedical engineering about $1.8 million to study ...
The first patient to undergo recently approved gene therapy for sickle cell disease, Kendric Cromer, has left the hospital.
A 12-year-old boy has become the first patient in the U.S. to receive gene therapy for sickle cell disease, The New York Times reported Oct ...
The gene editing company will focus on “in vivo” medicines, while seeking to license out or find a development partner for its clinical-stage treatment reni-cel.
The company will seek a strategic partner to continue development of APX3330, an oral small-molecule inhibitor of Ref-1 for ...
Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. | Pfizer has told 75 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback